Kyle Wang

ORCID: 0000-0002-8374-021X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Radiotherapy Techniques
  • Head and Neck Cancer Studies
  • Lung Cancer Diagnosis and Treatment
  • Cancer Cells and Metastasis
  • Cancer Genomics and Diagnostics
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Lung Cancer Treatments and Mutations
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Brain Metastases and Treatment
  • 3D Printing in Biomedical Research
  • Colorectal and Anal Carcinomas
  • Glioma Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Head and Neck Surgical Oncology
  • Medical Imaging Techniques and Applications
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Radiomics and Machine Learning in Medical Imaging
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Cancer Diagnosis and Treatment
  • Gastric Cancer Management and Outcomes
  • Colorectal Cancer Surgical Treatments
  • Management of metastatic bone disease
  • Autophagy in Disease and Therapy
  • Global Cancer Incidence and Screening

University of Cincinnati
2021-2025

University of Cincinnati Medical Center
2023-2024

Sabin Vaccine Institute
2024

Los Angeles Mission College
2023

University of North Carolina Hospitals
2016-2021

University of North Carolina at Chapel Hill
2013-2021

Villanova University
2021

The University of Queensland
2019

Texas State University
2018

UNC Lineberger Comprehensive Cancer Center
2017-2018

Purpose The significance of radiotherapy (RT) -associated cardiac injury for stage III non-small-cell lung cancer (NSCLC) is unclear, but higher heart doses were associated with worse overall survival in the Radiation Therapy Oncology Group (RTOG) 0617 study. We assessed impact dose patients treated at our institution on several prospective dose-escalation trials. Patients and Methods From 1996 to 2009, 127 NSCLC (Eastern Cooperative performance status, 0 1) received dose-escalated RT 70 90...

10.1200/jco.2016.70.0229 article EN Journal of Clinical Oncology 2017-02-23

BACKGROUND Stereotactic body radiotherapy (SBRT) is the standard of care for patients with nonoperative, early‐stage non–small cell lung cancer (NSCLC) measuring < 5 cm, but its use among tumors ≥5 cm considerably less defined, existing literature limited to small, single‐institution reports. The current multi‐institutional study reported outcomes evaluating largest such population date. METHODS Clinical/treatment characteristics, outcomes, toxicities, and patterns failure were assessed...

10.1002/cncr.30375 article EN Cancer 2016-10-14

The 5-year overall survival of pancreas adenocarcinoma (PCa) remains less than 10%. Clinical and tumor genomic characteristics have not differentiated PCa long-term survivors (LTSs) from unselected patients. Preclinical studies using fecal transplant experiments LTSs revealed delayed growth through unknown mechanisms involving the microbiota. However, features microbiome in patients with are well described.In this cross-sectional study, comprehensive shotgun metagenomics was performed on...

10.1002/cncr.34748 article EN cc-by-nc-nd Cancer 2023-03-21

Abstract Purpose: We aimed to examine the effects of multivalent binding and biomimetic cell rolling on sensitivity specificity circulating tumor (CTC) capture. also investigated clinical significance CTCs their kinetic profiles in patients with cancer undergoing radiotherapy treatment. Experimental Design: Patients histologically confirmed primary carcinoma radiotherapy, or without chemotherapy, were eligible for enrollment. Peripheral blood was collected prospectively at up five time...

10.1158/1078-0432.ccr-17-3078 article EN Clinical Cancer Research 2018-03-15

564 Background: A variety of local therapy options exist to treat Hepatocellular Carcinoma (HCC) including external radiotherapy (EBRT). Prior yttrium-90 (Y90) delivered transarterially is often a contraindication EBRT in clinical trials and guidelines due concerns cumulative hepatotoxicity, though data suggest higher rates hepatotoxicity limited. This study examines profiles after with without prior Y90 treatment using the ALBI grading system. Methods: Patients treated for HCC from 2016...

10.1200/jco.2025.43.4_suppl.564 article EN Journal of Clinical Oncology 2025-01-27

Telomeres are composed of simple tandem DNA repeats that protect the ends linear chromosomes from replicative erosion or inappropriate damage response mechanisms. The mammalian Protection Of (POT1) protein interacts with single-stranded telomeric and can exert positive negative effects on telomere length. four distinct POT1 homologs in roundworm Caenorhabditis elegans, deficiency for POT-1 POT-2 resulted progressive elongation occurred because both proteins negatively regulate telomerase. We...

10.1534/g3.112.004440 article EN cc-by G3 Genes Genomes Genetics 2013-02-01

Computed tomography (CT), combined positron emitted and CT (PET/CT), magnetic resonance imaging (MRI) are commonly used in head neck radiation planning. Hybrid PET/MRI has garnered attention for potential added value cancer staging treatment Herein, we compare vs. planning gross tumor volume (GTV) delineation.We prospectively enrolled patients with treated definitive chemoradiation to 60-70 Gy using IMRT. We performed pretreatment contrast-enhanced gadolinium-enhanced PET/MRI. Primary nodal...

10.3389/fonc.2017.00008 article EN cc-by Frontiers in Oncology 2017-01-23

Whole-brain radiation therapy (WBRT) delivers a substantial dose to the parotid glands, but glands are not delineated for avoidance and xerostomia has never been reported as an adverse effect. Minimizing toxic effects in patients receiving palliative treatments, such WBRT, is crucial.To assess whether effect of WBRT.This observational cohort study enrolled from November 2, 2015, March 20, 2018, at 1 academic center (University North Carolina Hospitals) 2 affiliated community hospitals (High...

10.1001/jamaoncol.2018.4951 article EN JAMA Oncology 2018-11-29

Background & Aims: Early-stage HCC can be treated with thermal ablation or stereotactic body radiation therapy (SBRT). We retrospectively compared local progression, mortality, and toxicity among patients SBRT in a multicenter, US cohort. Approach Results: included adult treatment-naïve lesions without vascular invasion per individual physician institutional preference from January 2012 to December 2018. Outcomes progression after 3-month landmark period assessed at the lesion level...

10.1097/hc9.0000000000000184 article EN cc-by-nc-nd Hepatology Communications 2023-06-14

Abstract Background Stereotactic body radiation therapy (SBRT) has seen increasing use as a salvage strategy for selected patients with recurrent, previously-irradiated squamous cell carcinoma of the head and neck (rSCCHN). PET-CT may be advantageous tumor delineation evaluation treatment failures in SBRT. We analyzed patterns failure following SBRT rSCCHN assessed impact planning on these failure. Methods retrospectively reviewed 96 treated Seven (7%) were after surgical resection 89 (93%)...

10.1186/1758-3284-4-12 article EN cc-by Head & Neck Oncology 2012-04-19
Coming Soon ...